Treating cancer using a telomerase vaccine
US7413864B2 · kind B2 · utility
7Cited by
57References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 24, 2004 |
| Grant date | Aug 19, 2008 |
| Priority date | — |
| Expiry date | Apr 12, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compositions and methods related to human telomerase reverse transcriptase (hTRT), the catalytic protein subunit of human telomerase. The polynucleotides and polypeptides of the invention are useful for diagnosis, prognosis and treatment of human diseases, for changing the proliferative capacity of cells and organisms, and for identification and screening of compounds and treatments useful for treatment of diseases such as cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.